That will include providing drug samples to health-care providers. Eli Lilly is also investing heavily in its ...

Dave Ricks became CEO of Eli Lilly in 2017, but has been working at different departments within the company since 1996. The ...

Even with this partial rebound, Lilly's share price remains roughly 13% below the peak set in late August. Some investors ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

Eli Lilly & Co. reported its results for the third quarter of 2024, with revenue up 20% y/y but failing to meet market ...